skip to search skip to navigation skip to main content

Archive: August 2016

Locally manufactured Astellas Overactive Bladder (OAB) therapy to be available to Iranian patients

25th August 2016 in Local Manufacturing Launches

Partnership between Astellas Pharma and Behphar Holding realises success following last year’s agreement.   Tehran, Iran; 25 August 2016: Global leader in urology, Astellas MENA/SSA announces the availability of Vesicare in Iran, which has been locally produced by the world-class facility of Behestan Tolid. This milestone comes after the partnership agreement signed last year between…

Read Full Post

Privacy Policy  |  Terms of Use  |  Cookies PolicyCopyright © 2020 Astellas Pharma